Department of Paediatrics, Turku University Hospital, Turku, Finland.
Early Hum Dev. 2012 Jun;88(6):339-44. doi: 10.1016/j.earlhumdev.2011.09.006. Epub 2011 Sep 25.
The breast milk bioactive substances such as adiponectin, have a presumably long-term impact upon the health and well-being of a child.
To determine the impact of probiotic-supplemented dietary counseling during pregnancy on colostrum adiponectin concentration.
Altogether 256 pregnant women were randomized into three study groups: dietary intervention with probiotics (diet/probiotics) or with placebo (diet/placebo) and a control group (control/placebo). The intervention group received dietary counseling provided by a nutritionist, the main focus being the amount and the type of dietary fat. The probiotics used were Lactobacillus rhamnosus GG and Bifidobacterium lactis in combination. Dietary intake was evaluated by food records at every trimester of pregnancy. Breast milk samples were collected after birth (colostrum) for adiponectin concentration analysis (n=181).
The dietary intervention increased the colostrum adiponectin concentration (ng/mL, geometric mean [95% CI]), the difference being significant when comparing to the control group; 12.7 [10.6-29.7] vs. 10.2 [9.9-13.2], P=0.024. Maternal weight gain during pregnancy (kg) correlated inversely with colostrum adiponectin concentration; β (SE)=-1.7 (0.1), P=0.020, and gestational diabetes mellitus was associated with the likelihood of adiponectin concentration falling into the lowest quartile; OR 2.36, 95% CI 1.1-3.2, P=0.028.
In showing that the colostrum adiponectin concentration is markedly dependent on maternal diet and nutritional status during pregnancy, and considering that colostrum adiponectin has potential effects on metabolism, nutrition, and immune function in the neonates, the results of this study underscore the importance of the metabolic homeostasis of the mother for the child's initial nutritional environment.
母乳中的生物活性物质,如脂联素,对儿童的健康和幸福可能会产生长期影响。
确定在妊娠期间补充益生菌的饮食咨询对初乳脂联素浓度的影响。
共有 256 名孕妇被随机分为三组:饮食干预加益生菌(饮食/益生菌)或安慰剂(饮食/安慰剂)和对照组(安慰剂/安慰剂)。干预组接受营养师提供的饮食咨询,主要关注饮食中脂肪的数量和类型。使用的益生菌为鼠李糖乳杆菌 GG 和双歧杆菌 lactis。在妊娠的每三个月通过食物记录评估饮食摄入。分娩后收集母乳样本(初乳)进行脂联素浓度分析(n=181)。
饮食干预增加了初乳脂联素浓度(ng/mL,几何均数[95%CI]),与对照组相比差异有统计学意义;12.7[10.6-29.7]vs.10.2[9.9-13.2],P=0.024。妊娠期间的体重增加(kg)与初乳脂联素浓度呈负相关;β(SE)=-1.7(0.1),P=0.020,妊娠期糖尿病与脂联素浓度落入最低四分位数的可能性相关;OR2.36,95%CI1.1-3.2,P=0.028。
本研究表明,初乳脂联素浓度明显取决于孕妇在妊娠期间的饮食和营养状况,并且考虑到初乳脂联素有潜在的影响代谢、营养和新生儿的免疫功能,因此本研究结果强调了母亲代谢平衡对儿童初始营养环境的重要性。